Takashi Oshima

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Do‐Youn Oh, Patricio Yañez et al. · The Lancet Oncology · 2023 · 521 citations

Chemotherapy Versus Placebo, Gastrointestinal Oncology, Medicine +8

Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2

Takashi Oshima, Masahiro Abe, Jin Asano et al. · Blood · 2005 · 343 citations · Full text

Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion

Masahiro Abe, Kenji Hiura, Javier Wilde et al. · Blood · 2004 · 314 citations

Impact of infectious complications on gastric cancer recurrence

Tsutomu Hayashi, Takaki Yoshikawa, Toru Aoyama et al. · Gastric Cancer · 2014 · 121 citations · Full text

Gastrointestinal Oncology, Medicine, Cancer Recurrence +5

Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study

Hannah Sophie Muti, Lara R. Heij, Gisela Keller et al. · The Lancet Digital Health · 2021 · 116 citations · Full text